Stocks

Pfizer’s COVID-19 vaccine lifts quarterly results

Pfizer Inc. significantly increased revenue projections from its Covid-19 vaccine for the year, as sales from the shot over the first three months of 2021 lifted the company to a stronger quarterly profit.

Record share of companies are beating earnings estimates

With the earnings season more than halfway over, most companies in the S&P 500 have surpassed analysts’ profit expectations. As of Friday, results from 87% of those that have reported were better than expected, according to Refinitiv. That is above the historical average of 65% and on pace for the highest share since Refinitiv began tracking the metric in 1994.